Stock listing
NASDAQ:ONCY Oncolytics Biotech Inc. Stock
Home listing (NASDAQ) of Oncolytics Biotech Inc.
Follow Oncolytics Biotech Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:ONCY
$0.40 USD -0.03 (-6.0%)
Close on Nov 2, 2026
- Day range
- $0.394 – $0.426 USDNov 2, 2026
- Volume
- 843,407 sharesNov 2, 2026
- Market cap
- $52.45M USDAt the close on Nov 2, 2026 · price × 131.1M shares outstanding
- 52-week range
- $0.394 – $1.30 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $680,601 USDMedian day 764,177 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ONCY · Home | $0.40 USD | -0.025 (-6.0%) | 843,407 | $0.424 | $0.426 | $0.394 | $0.425 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:ONCY · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.40 | -0.025 | -6.0% | $0.424 | $0.426 | $0.394 | 843,407 | |
| $0.425 | -0.002 | -0.5% | $0.421 | $0.43 | $0.405 | 764,177 | |
| $0.428 | -0.014 | -3.1% | $0.44 | $0.45 | $0.425 | 606,744 | |
| $0.442 | -0.021 | -4.5% | $0.46 | $0.463 | $0.43 | 2,189,089 | |
| $0.462 | -0.011 | -2.3% | $0.474 | $0.50 | $0.46 | 847,183 | |
| $0.473 | -0.027 | -5.4% | $0.51 | $0.52 | $0.472 | 694,532 | |
| $0.50 | 0.00 | 0.0% | $0.51 | $0.51 | $0.49 | 375,800 | |
| $0.50 | -0.01 | -2.0% | $0.50 | $0.52 | $0.50 | 405,600 | |
| $0.51 | +0.01 | +2.0% | $0.50 | $0.52 | $0.49 | 771,600 | |
| $0.50 | 0.00 | 0.0% | $0.51 | $0.52 | $0.49 | 1,198,100 | |
| $0.50 | 0.00 | 0.0% | $0.51 | $0.55 | $0.49 | 690,500 | |
| $0.50 | -0.05 | -9.1% | $0.55 | $0.55 | $0.49 | 1,336,600 | |
| $0.55 | +0.01 | +1.9% | $0.55 | $0.59 | $0.52 | 1,300,700 | |
| $0.54 | +0.05 | +10.2% | $0.50 | $0.56 | $0.44 | 3,155,000 | |
| $0.49 | +0.02 | +4.3% | $0.49 | $0.50 | $0.45 | 4,202,500 | |
| $0.47 | -0.09 | -16.1% | $0.57 | $0.59 | $0.44 | 3,317,400 | |
| $0.56 | +0.02 | +3.7% | $0.55 | $0.57 | $0.53 | 1,459,000 | |
| $0.54 | -0.06 | -10.0% | $0.60 | $0.61 | $0.54 | 1,122,200 | |
| $0.60 | 0.00 | 0.0% | $0.59 | $0.61 | $0.58 | 669,000 | |
| $0.60 | 0.00 | 0.0% | $0.60 | $0.61 | $0.58 | 858,500 | |
| $0.60 | -0.03 | -4.8% | $0.64 | $0.64 | $0.58 | 1,936,400 | |
| $0.63 | -0.01 | -1.6% | $0.65 | $0.65 | $0.62 | 609,300 | |
| $0.64 | -0.03 | -4.5% | $0.67 | $0.68 | $0.63 | 689,800 | |
| $0.67 | 0.00 | 0.0% | $0.68 | $0.68 | $0.65 | 867,000 | |
| $0.67 | +0.01 | +1.5% | $0.67 | $0.68 | $0.66 | 779,000 | |
| $0.66 | -0.02 | -2.9% | $0.68 | $0.72 | $0.66 | 1,129,200 | |
| $0.68 | 0.00 | 0.0% | $0.69 | $0.69 | $0.67 | 822,000 | |
| $0.68 | 0.00 | 0.0% | $0.68 | $0.69 | $0.64 | 1,213,700 | |
| $0.68 | -0.03 | -4.2% | $0.73 | $0.73 | $0.66 | 1,890,900 | |
| $0.71 | -0.06 | -7.8% | $0.76 | $0.78 | $0.71 | 2,075,200 | |
| $0.77 | 0.00 | 0.0% | $0.77 | $0.79 | $0.76 | 693,300 | |
| $0.77 | 0.00 | 0.0% | $0.78 | $0.78 | $0.76 | 491,500 | |
| $0.77 | 0.00 | 0.0% | $0.78 | $0.80 | $0.77 | 594,200 | |
| $0.77 | -0.01 | -1.3% | $0.78 | $0.80 | $0.76 | 958,300 | |
| $0.78 | -0.03 | -3.7% | $0.83 | $0.84 | $0.78 | 903,100 | |
| $0.81 | +0.06 | +8.0% | $0.76 | $0.85 | $0.76 | 1,399,400 | |
| $0.75 | -0.02 | -2.6% | $0.77 | $0.77 | $0.73 | 1,198,300 | |
| $0.77 | -0.03 | -3.8% | $0.79 | $0.83 | $0.76 | 3,787,600 | |
| $0.80 | -0.01 | -1.2% | $0.80 | $0.83 | $0.79 | 741,300 | |
| $0.81 | -0.03 | -3.6% | $0.83 | $0.84 | $0.79 | 1,140,800 | |
| $0.84 | -0.02 | -2.3% | $0.84 | $0.85 | $0.83 | 463,700 | |
| $0.86 | -0.02 | -2.3% | $0.88 | $0.89 | $0.84 | 582,800 | |
| $0.88 | +0.04 | +4.8% | $0.85 | $0.91 | $0.84 | 1,585,400 | |
| $0.84 | 0.00 | 0.0% | $0.83 | $0.86 | $0.83 | 435,100 | |
| $0.84 | -0.02 | -2.3% | $0.85 | $0.87 | $0.83 | 428,900 | |
| $0.86 | +0.01 | +1.2% | $0.84 | $0.86 | $0.82 | 673,100 | |
| $0.85 | -0.01 | -1.2% | $0.86 | $0.87 | $0.84 | 569,100 | |
| $0.86 | 0.00 | 0.0% | $0.86 | $0.87 | $0.84 | 410,100 | |
| $0.86 | +0.02 | +2.4% | $0.85 | $0.87 | $0.84 | 775,300 | |
| $0.84 | 0.00 | 0.0% | $0.85 | $0.85 | $0.80 | 486,400 | |
| $0.84 | +0.04 | +5.0% | $0.80 | $0.85 | $0.80 | 539,900 | |
| $0.80 | -0.03 | -3.6% | $0.83 | $0.83 | $0.79 | 682,000 | |
| $0.83 | -0.01 | -1.2% | $0.84 | $0.86 | $0.83 | 608,700 | |
| $0.84 | +0.02 | +2.4% | $0.82 | $0.86 | $0.82 | 798,700 | |
| $0.82 | -0.01 | -1.2% | $0.84 | $0.85 | $0.81 | 523,100 | |
| $0.83 | +0.03 | +3.7% | $0.80 | $0.85 | $0.78 | 1,128,000 | |
| $0.80 | -0.02 | -2.4% | $0.84 | $0.84 | $0.80 | 586,900 | |
| $0.82 | 0.00 | 0.0% | $0.80 | $0.83 | $0.79 | 716,000 | |
| $0.82 | +0.02 | +2.5% | $0.80 | $0.83 | $0.78 | 673,000 | |
| $0.80 | 0.00 | 0.0% | $0.80 | $0.81 | $0.76 | 813,600 | |
| $0.80 | 0.00 | 0.0% | $0.80 | $0.82 | $0.79 | 571,300 | |
| $0.80 | 0.00 | 0.0% | $0.79 | $0.82 | $0.79 | 555,300 | |
| $0.80 | -0.01 | -1.2% | $0.80 | $0.81 | $0.78 | 431,300 | |
| $0.81 | +0.03 | +3.8% | $0.80 | $0.82 | $0.78 | 578,600 | |
| $0.78 | +0.03 | +4.0% | $0.75 | $0.79 | $0.75 | 746,900 |
- Ticker
- NASDAQ:ONCY
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 27, 2026
Oncolytics Biotech® Reports Strong Durability and Survival Data in Anal Cancer, Positioning Pelareorep as Potential Backbone Immunotherapy Across HPV-Driven Cancers
Latest deck · August 2026
Investor Presentation (August 2026)
Investor deck · 27 slides
Calls
Replays
Oncolytics Biotech (NASDAQ:ONCY) Q2 2025 Earnings Call
Thu, Aug 07, 2025 · 4:30 PM ET
Watch TranscriptOncolytics Biotech (NASDAQ:ONCY) Q1 2025 Earnings Call
Wed, May 14, 2025 · 4:30 PM ET
Watch TranscriptOncolytics Biotech (NASDAQ:ONCY) Q4 2024 Earnings Call
Fri, Mar 07, 2025 · 8:30 AM ET
Watch Transcript
Latest news
Oncolytics Biotech® Reports Strong Durability and Survival Data in Anal Cancer, Positioning Pelareorep as Potential Backbone Immunotherapy Across HPV-Driven Cancers
Oct 27, 2026
Closed $0.462 (-2.3%) on Oct 27, 2026
Oncolytics Biotech® to Present REO 033 Trial in Progress Abstract at ESMO Showcasing Pelareorep’s Potential in Colorectal Cancer
Oct 20, 2026
Closed $0.50 (0.0%) on Oct 20, 2026
Oncolytics Biotech® Provides Update on GOBLET Study Clinical Data and Final PanCAN Grant Payment
Oct 14, 2026
Closed $0.54 (+10.2%) on Oct 14, 2026
Oncolytics Biotech® Secures Patent Protection to Late 2040s and Provides Intellectual Property Portfolio Update
Oct 12, 2026
Closed $0.49 (+4.3%) on Oct 13, 2026
Oncolytics Biotech® Announces Publication Demonstrating Pelareorep Creates Immune Responses in Liver Cancer That Make Tumors Susceptible to Immunotherapy
Sep 29, 2026
Closed $0.67 (+1.5%) on Sep 29, 2026
Oncolytics Biotech® Reports Accelerating Enrollment in Randomized REO 033 RAS-Mutant, MSS Colorectal Cancer Study
Sep 28, 2026
Closed $0.66 (-2.9%) on Sep 28, 2026
Oncolytics Biotech® Announces Positive Preclinical Results Combining Pelareorep with a Pan-RAS Inhibitor in Colorectal Cancer
Sep 10, 2026
Closed $0.77 (-3.8%) on Sep 10, 2026
Oncolytics Biotech® Aligns with FDA on Registrational Path for Second-Line RAS-Mutant MSS Colorectal Cancer
Aug 18, 2026
Closed $0.84 (+2.4%) on Aug 18, 2026
Oncolytics Biotech® Receives Fast Track Designation for Pelareorep in Second-Line and Later Anal Cancer
Jul 20, 2026
Closed $0.85 (0.0%) on Jul 20, 2026
Decks
Investor Presentation (August 2026)
Investor deck · 27 slides · August 2026
Investor Presentation (June 2026)
Investor deck · 27 slides · June 2026
Investor Presentation (April 2026)
Investor deck · 26 slides · April 2026
Investor Presentation (March 2026)
Investor deck · 23 slides · March 2026
Oncolytics Biotech Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 36 in the last 12 months · 307 in all · newest Oct 27, 2026 · oldest 2016
- Calls
- 16 calls with a replay · 16 with a transcript · latest Aug 7, 2025
- Decks
- 22 decks · latest August 2026
Where Oncolytics Biotech Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ONCY · Home listing · This page | NASDAQ | United States | USD |
| BOATS:ONCY | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Oncolytics Biotech Inc.